Maximiliano Van Kooten
About Maximiliano Van Kooten
Maximiliano Van Kooten is the Clinical Development Lead for Renal-Prostate Cancer at Bristol Myers Squibb in Boudry, Neuchâtel, Switzerland, with over 15 years of experience in oncology and onco-hematology.
Title
Maximiliano Van Kooten holds the position of Clinical Development Lead, Renal-Prostate Cancer, at Bristol Myers Squibb. He is currently based in Boudry, Neuchâtel, Switzerland.
Current Role at Bristol Myers Squibb
Maximiliano Van Kooten is the Clinical Development Lead for Renal-Prostate Cancer at Bristol Myers Squibb. In this role, he is involved in overseeing the clinical development of new treatments and therapies for renal and prostate cancers.
Previous Roles at Bristol Myers Squibb
Before his current position, Maximiliano served as Head of Medical - CEETII at Bristol Myers Squibb from 2020 to 2021 in Switzerland. In this role, he led medical strategy and operations for a year, focusing on Central and Eastern Europe, Turkey, Israel, and India, contributing to regional medical affairs and clinical development initiatives.
Experience at Celgene and Johnson & Johnson
Maximiliano was the Executive Medical Director, International Markets, at Celgene from 2019 to 2020 in Boudry, Canton of Neuchâtel, Switzerland. He also worked at Johnson & Johnson in several roles, including Oncology TA Lead Asia Pacific Region in Sydney, Australia (2016-2018), Oncology Clinical Development Lead in Beijing City, China (2015-2016), and Therapeutic Area Lead, Oncology Medical Affairs, Asia-Pacific Region (2013-2015).
Early Career in Oncology
His early career includes roles such as Global Clinical Lead & Medical Affairs for Bendamustine and Franchise Medical Director, Oncology Medical Affairs at Janssen Pharmaceutical Companies of Johnson & Johnson. He worked as Senior Medical Advisor Oncology at Eli Lilly Australia and as Senior Clinical Research Physician. Additionally, he served as Medical Oncologist at Hospital de Rehabilitacion Respiratoria Maria Ferrer for six years and as Head of Thoracic Oncology at Instituto Alexander Fleming for twelve years.
Education and Training
Maximiliano obtained his Bachelor's degree from Eduardo L.Holmberg, Quilmes. He holds an MD in Internal Medicine and Medical Oncology from the University of Buenos Aires, where he studied from 1983 to 1994. He also studied Oncology at the European Society for Medical Oncology in 2018 and the Philosophy of Science at the University of Oxford. Maximiliano furthered his education with MITx's course in Economy in 2020.